Viewing Study NCT03376958


Ignite Creation Date: 2025-12-25 @ 12:18 AM
Ignite Modification Date: 2026-02-20 @ 8:15 PM
Study NCT ID: NCT03376958
Status: COMPLETED
Last Update Posted: 2019-07-25
First Post: 2017-10-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Apatinib for Relapsed and Refractory Diffuse Large B Cell Lymphoma
Sponsor: Zhengzhou University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed and Refractory View
None Diffuse Large B Cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None R R DLBCL View
None ORR View
None PFS View
None OS View